Lizama BN, DiCaro V, Cho E, et al. Plasma Proteomic Analysis of a Biomarker-defined Subpopulation in the SHINE Ph2 Trial
to Identify Molecular Correlates to the Favorable Decrease in the Neuroinflammatory Marker GFAP with Zervimesine in Alzheimer’s Disease Participants. Poster presented at 2025 Alzheimer’s Association International Conference (AAIC); Toronto, Ontario, Canada